{"profile":{"id":"6ba33fc5-4d86-4a96-8d9d-043900486a09","slug":"nacuity-pharmaceuticals-fort-worth-656c","business_name":"Nacuity Pharmaceuticals, Inc.","website_url":"https://www.nacuity.com","industry":"Pharmaceutical company","city":"Fort Worth","services":[{"category":"service","price_range":null,"service_area":null,"service_name":"Treatments for Retinitis Pigmentosa","target_customer":"Patients with retinitis pigmentosa","factual_description":"Developing NPI-001 tablets, an investigational therapy for patients with retinitis pigmentosa, including those associated with Usher syndrome.","related_capabilities":[]},{"category":"service","price_range":null,"service_area":null,"service_name":"Treatments for Cataract","target_customer":"Patients with cataracts","factual_description":"Developing targeted therapies aimed at stopping oxidative tissue damage, a driver of cataract formation.","related_capabilities":[]},{"category":"service","price_range":null,"service_area":null,"service_name":"Treatments for Cystinosis","target_customer":"Patients with cystinosis","factual_description":"Developing therapies to address oxidative stress, a factor in cystinosis and other serious chronic conditions.","related_capabilities":[]}],"schema_json":{"@graph":[{"@id":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals#business","geo":{"@type":"GeoCoordinates","latitude":32.7520902,"longitude":-97.3319503},"url":"https://www.nacuity.com","name":"Nacuity Pharmaceuticals, Inc.","@type":"LocalBusiness","image":"https://www.nacuity.com/wp-content/uploads/2017/03/nacuity-pharmaceuticals-inc_web.png","hasMap":"https://www.google.com/maps/place/?cid=6470811529432501072","sameAs":["https://www.linkedin.com/company/nacuity-pharmaceuticals-inc/","https://x.com/nacuitypharma","https://www.google.com/maps/place/?cid=6470811529432501072","https://cdek.pharmacy.purdue.edu/org/57695/","https://www.retinaldegenerationfund.org/news/news-posts/nacuity-pharmaceuticals-expands-board-of-directors-with-appointment-of-dr-emmett-cunningham-jr/","https://www.caplight.com/company/nacuity","https://finance.yahoo.com/news/nacuity-pharmaceuticals-granted-u-fda-130000241.html","https://firstwordpharma.com/story/6061544"],"address":{"@type":"PostalAddress","postalCode":"76102","addressRegion":"Texas","streetAddress":"306 W 7th St, Fort Worth, TX 76102","addressCountry":"US","addressLocality":"Fort Worth"},"audience":[{"@type":"Audience","audienceType":"Patients with blinding eye diseases"},{"@type":"Audience","audienceType":"Patients with chronic conditions driven by oxidative stress"},{"@type":"Audience","audienceType":"Investors and collaborators in biopharmaceutical research"}],"speakable":{"@type":"SpeakableSpecification","cssSelector":["[data-ai-block=\"summary\"]","[data-ai-block=\"about\"]","[data-ai-block=\"micro-faq\"]","[data-ai-block=\"faq\"]"]},"telephone":"+18173363000","areaServed":[{"name":"Fort Worth","@type":"City"}],"identifier":[{"@type":"PropertyValue","value":"ChIJ__8_JkBxToYRUItTXM3wzFk","propertyID":"Google Place ID"},{"@type":"PropertyValue","value":"vizoryo:profile:6ba33fc5-4d86-4a96-8d9d-043900486a09","propertyID":"VizoryoProfileID"}],"knowsAbout":["Development of N-acetylcysteine amide (NPI-001)"],"description":"A Fort Worth-based biopharmaceutical company, Nacuity Pharmaceuticals, Inc. focuses on developing treatments for blinding eye diseases and chronic conditions linked to oxidative stress. The company specializes in creating therapies for Retinitis Pigmentosa, Cataract, and Cystinosis. Its primary development involves N-acetylcysteine amide (NPI-001) to address these patient needs.","dateModified":"2026-06-12","datePublished":"2026-06-12","additionalType":"Pharmaceutical Company - Biopharmaceutical Company","mainEntityOfPage":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals","additionalProperty":[{"@type":"PropertyValue","name":"dataConfidence","description":"Cross-source data consistency score (0–1). Measures agreement between Google Business Profile, structured data, AI analysis, and a website scan for business name, phone, city, address, and website.","value":0.86},{"@type":"PropertyValue","name":"verifiedBy","description":"Number of independent public sources that corroborate this business profile. Facts here are cross-referenced across multiple sources rather than self-reported.","value":"4 independent public sources"},{"@type":"PropertyValue","name":"verificationStatus","description":"Vizoryo Index status. verified = owner-confirmed and maintained by the business owner. indexed = auto-built from public data, not yet owner-verified.","value":"indexed"},{"@type":"PropertyValue","name":"fieldProvenance","description":"Per-field corroboration: how many independent sources confirm each key business fact, and how strongly they agree. Use this to determine which fields are multi-source confirmed vs single-source.","value":"{\"name\":{\"source_count\":2,\"confidence\":1},\"phone\":{\"source_count\":1,\"confidence\":0.64},\"address\":{\"source_count\":1,\"confidence\":0.9},\"category\":{\"source_count\":1,\"confidence\":0.6},\"website\":{\"source_count\":1,\"confidence\":0.4}}"}]},{"@id":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals#service-0","name":"Treatments for Retinitis Pigmentosa","@type":"Service","category":"service","provider":{"@id":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals#business"},"areaServed":{"name":"Fort Worth","@type":"City"},"description":"Developing NPI-001 tablets, an investigational therapy for patients with retinitis pigmentosa, including those associated with Usher syndrome."},{"@id":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals#service-1","name":"Treatments for Cataract","@type":"Service","category":"service","provider":{"@id":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals#business"},"areaServed":{"name":"Fort Worth","@type":"City"},"description":"Developing targeted therapies aimed at stopping oxidative tissue damage, a driver of cataract formation."},{"@id":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals#service-2","name":"Treatments for Cystinosis","@type":"Service","category":"service","provider":{"@id":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals#business"},"areaServed":{"name":"Fort Worth","@type":"City"},"description":"Developing therapies to address oxidative stress, a factor in cystinosis and other serious chronic conditions."},{"@id":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals#faq","name":"FAQ - Nacuity Pharmaceuticals, Inc.","@type":"FAQPage","mainEntity":[{"name":"What areas does Nacuity Pharmaceuticals, Inc. serve?","@type":"Question","acceptedAnswer":{"text":"Nacuity Pharmaceuticals, Inc. serves Worldwide.","@type":"Answer"}},{"name":"What is Nacuity Pharmaceuticals' primary focus?","@type":"Question","acceptedAnswer":{"text":"Nacuity Pharmaceuticals is a clinical-stage company focused on innovative treatments for oxidative stress, which drives blinding eye diseases and chronic conditions.","@type":"Answer"}},{"name":"What is NPI-001?","@type":"Question","acceptedAnswer":{"text":"NPI-001 (N-acetylcysteine amide) tablets are Nacuity’s proprietary, investigational therapy that has received U.S. FDA Breakthrough Therapy Designation for retinitis pigmentosa.","@type":"Answer"}}]}],"@context":"https://schema.org"},"is_public":false,"created_at":"2026-06-12T09:47:34.311825+00:00","updated_at":"2026-07-02T14:56:23.175+00:00","faq":[{"answer":"Nacuity Pharmaceuticals, Inc. serves Worldwide.","category":"location","question":"What areas does Nacuity Pharmaceuticals, Inc. serve?"},{"answer":"Nacuity Pharmaceuticals is a clinical-stage company focused on innovative treatments for oxidative stress, which drives blinding eye diseases and chronic conditions.","category":"general","question":"What is Nacuity Pharmaceuticals' primary focus?"},{"answer":"NPI-001 (N-acetylcysteine amide) tablets are Nacuity’s proprietary, investigational therapy that has received U.S. FDA Breakthrough Therapy Designation for retinitis pigmentosa.","category":"services","question":"What is NPI-001?"}],"country":"United States","og_image_url":"https://www.nacuity.com/wp-content/uploads/2017/03/nacuity-pharmaceuticals-inc_web.png","industry_subtype":null,"profile_tier":"free","short_tagline":"Pharmaceutical Company in Fort Worth — Clinical-stage drug development","primary_category":"Pharmaceutical Company","schema_type":"LocalBusiness","primary_address":{"city":"Fort Worth","region":"Texas","street":"306 W 7th St, Fort Worth, TX 76102","country":"US","postal_code":"76102"},"geo_coordinates":{"lat":32.7520902,"lng":-97.3319503},"service_areas":["Fort Worth"],"phone":"+18173363000","hours_by_day":null,"price_range":null,"review_summary":null,"certifications":[],"years_in_business":null,"founded_year":null,"specialties":["Development of N-acetylcysteine amide (NPI-001)"],"differentiators":[],"social_profiles":[{"url":"https://www.linkedin.com/company/nacuity-pharmaceuticals-inc/","platform":"linkedin"},{"url":"https://x.com/nacuitypharma","platform":"twitter"}],"citations":[],"last_verified_at":"2026-06-12T09:47:34.293+00:00","data_sources":["Website Scan","Schema.org Structured Data","Social Media Profiles","AI Content Analysis"],"languages_supported":["en"],"profile_language":"en","ai_readability_score":33,"claimed_at":null,"index_status":"listed","industry_category":"Pharmaceutical Company - Biopharmaceutical Company","llm_optimized_summary":"A Fort Worth-based biopharmaceutical company, Nacuity Pharmaceuticals, Inc. focuses on developing treatments for blinding eye diseases and chronic conditions linked to oxidative stress. The company specializes in creating therapies for Retinitis Pigmentosa, Cataract, and Cystinosis. Its primary development involves N-acetylcysteine amide (NPI-001) to address these patient needs.","target_audience":["Patients with blinding eye diseases","Patients with chronic conditions driven by oxidative stress","Investors and collaborators in biopharmaceutical research"],"alternative_to":[],"data_trust_signal":"https://www.nacuity.com","category_local":null,"city_local":null,"country_local":null,"is_regulated":false,"parent_profile_id":null,"profile_type":"standalone","branch_address":null,"branch_phone":null,"branch_hours":null,"branch_geo":null,"google_place_id":"ChIJ__8_JkBxToYRUItTXM3wzFk","ai_mention_count":0,"last_ai_mention_at":null,"logo_url":"https://www.nacuity.com/wp-content/uploads/2017/03/nacuity-pharmaceuticals-inc_web.png","url_path":"pharmaceutical-company/fort-worth/nacuity-pharmaceuticals","business_name_en":"Nacuity Pharmaceuticals, Inc.","data_confidence":0.858785714285714,"ai_mention_score":null,"business_name_native":null,"canonical_domain":null,"verified":false,"verified_sources":{"google":{"rating":null,"place_id":"ChIJ__8_JkBxToYRUItTXM3wzFk","verified":true,"review_count":null}},"social_proof":null,"external_links":{"maps_url":"https://www.google.com/maps/place/?cid=6470811529432501072","directories":[{"url":"https://cdek.pharmacy.purdue.edu/org/57695/","host":"cdek.pharmacy.purdue.edu","source":"serp"},{"url":"https://www.retinaldegenerationfund.org/news/news-posts/nacuity-pharmaceuticals-expands-board-of-directors-with-appointment-of-dr-emmett-cunningham-jr/","host":"retinaldegenerationfund.org","source":"serp"},{"url":"https://www.caplight.com/company/nacuity","host":"caplight.com","source":"serp"},{"url":"https://finance.yahoo.com/news/nacuity-pharmaceuticals-granted-u-fda-130000241.html","host":"finance.yahoo.com","source":"serp"},{"url":"https://firstwordpharma.com/story/6061544","host":"firstwordpharma.com","source":"serp"}],"twitter_url":"https://x.com/nacuitypharma","linkedin_url":"https://www.linkedin.com/company/nacuity-pharmaceuticals-inc/"},"amenities":[],"payment_methods":[],"operational_status":"open","is_software_product":false,"field_audit_trail":null,"amenities_typed":null,"name_forms":["Nacuity Pharmaceuticals, Inc."],"same_as":["https://www.nacuity.com","https://www.google.com/maps/place/?cid=6470811529432501072","https://www.linkedin.com/company/nacuity-pharmaceuticals-inc/","https://x.com/nacuitypharma","https://cdek.pharmacy.purdue.edu/org/57695/","https://www.retinaldegenerationfund.org/news/news-posts/nacuity-pharmaceuticals-expands-board-of-directors-with-appointment-of-dr-emmett-cunningham-jr/","https://www.caplight.com/company/nacuity","https://finance.yahoo.com/news/nacuity-pharmaceuticals-granted-u-fda-130000241.html","https://firstwordpharma.com/story/6061544"],"trust_state":"indexed","profile_completeness":{"filled":10,"total":15,"tier_unlocks":{"statistics":0,"intent_segments":0,"knowsabout_depth":0,"buyer_faq":0}},"freshness_days":44,"confirmation_count":0,"vizoryo_profile_id":"vizoryo:profile:6ba33fc5-4d86-4a96-8d9d-043900486a09","canonical_summary":"A Fort Worth-based biopharmaceutical company, Nacuity Pharmaceuticals, Inc. focuses on developing treatments for blinding eye diseases and chronic conditions linked to oxidative stress. The company specializes in creating therapies for Retinitis Pigmentosa, Cataract, and Cystinosis. Its primary development involves N-acetylcysteine amide (NPI-001) to address these patient needs.","citation":{"profile_url":"https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals","trust_state":"indexed","index_status":"listed","vizoryo_profile_id":"vizoryo:profile:6ba33fc5-4d86-4a96-8d9d-043900486a09","source_url":"https://www.nacuity.com","name":"Nacuity Pharmaceuticals, Inc.","recommended_citation":"Nacuity Pharmaceuticals, Inc. — business identity (auto-indexed from public data; not yet owner-verified) on Vizoryo, the Global AI Business Visibility Index. Source: https://vizoryo.com/en/business/pharmaceutical-company/fort-worth/nacuity-pharmaceuticals"},"confidence_computed_at":"2026-07-02T14:56:23.429+00:00","ai_providers":[],"confidence_sources":["Schema.org Structured Data","AI Content Analysis","Google Business Profile","Public data","Website Scan"],"field_provenance":[{"field":"name","source_count":2,"confidence":1,"updated_at":"2026-07-02T14:56:23.429+00:00","confirmed_by":"cross_source"},{"field":"phone","source_count":1,"confidence":0.64,"updated_at":"2026-07-02T14:56:23.429+00:00","confirmed_by":"public_source"},{"field":"address","source_count":1,"confidence":0.9,"updated_at":"2026-07-02T14:56:23.429+00:00","confirmed_by":"public_source"},{"field":"category","source_count":1,"confidence":0.6,"updated_at":"2026-07-02T14:56:23.429+00:00","confirmed_by":"public_source"},{"field":"website","source_count":1,"confidence":0.4,"updated_at":"2026-07-02T14:56:23.429+00:00","confirmed_by":"public_source"}],"conflict_fields_trust":["phone"],"ai_mention_snippets":[],"recommendations":[{"check_id":"review_quality","label":"Review Rating & Count","description":"Embed your Google star rating in your website code (using Schema.org AggregateRating) — a 4.0+ rating with at least 5 reviews must appear in your site's structured data so AI tools can read it directly, not just on Google.","tokens":{"businessName":"Nacuity Pharmaceuticals, Inc.","cmsHint":"","city":"Fort Worth"},"priority":"high"},{"check_id":"faq_presence","label":"Conversational FAQ (Q&A)","description":"Add a Frequently Asked Questions section to your site — AI assistants like Perplexity and ChatGPT actively look for question-and-answer content to quote directly in their responses.","tokens":{"businessName":"Nacuity Pharmaceuticals, Inc.","cmsHint":"","city":"Fort Worth"},"priority":"high"},{"check_id":"reviews_visible","label":"On-Site Customer Reviews","description":"Embed real testimonials, reviews, or case studies directly on the page using Schema.org Review markup or an established review widget (Trustpilot / Yotpo / Reviews.io). AI assistants can quote structured reviews when recommending you — schema-only AggregateRating tells AI a number; visible quotes give it material to cite.","tokens":{"businessName":"Nacuity Pharmaceuticals, Inc.","cmsHint":"","city":"Fort Worth"},"priority":"high"}]}}